Wang Yujia, Peng Xiaoping
Queen Mary College of Nanchang University, Nanchang, Jiangxi 330006, China.
Department of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China.
Transpl Immunol. 2024 Jun;84:102036. doi: 10.1016/j.trim.2024.102036. Epub 2024 Mar 16.
Cardiac allograft rejection (AR) remains a significant complication following heart transplantation. The primary objective of our study is to gain a comprehensive understanding of the fundamental mechanisms involved in AR and identify possible therapeutic targets.
We acquired the GSE87301 dataset from the Gene Expression Omnibus database. In GSE87301, a comparison was conducted on blood samples from patients with and without cardiac allograft rejection (AR and NAR) to detect differentially expressed genes (DEGs). Enrichment analysis was conducted to identify the pathways that show significant enrichment during AR. Machine learning techniques, including the least absolute shrinkage and selection operator regression (LASSO) and random forest (RF) algorithms, were employed to identify potential genes for the diagnosis of AR. The diagnostic value was evaluated using a nomogram and receiver operating characteristic (ROC) curve. Additionally, immune cell infiltration was analyzed to explore any dysregulation of immune cells in AR.
A total of 114 DEGs were identified from the GSE87301 dataset. These DEGs were mainly found to be enriched in pathways related to the immune system. To identify the signature genes, the LASSO and RF algorithms were used, and four genes, namely ALAS2, HBD, EPB42, and FECH, were identified. The performance of these signature genes was evaluated using the receiver operating characteristic curve (ROC) analysis, which showed that the area under the curve (AUC) values for ALAS2, HBD, EPB42, and FECH were 0.906, 0.881, 0.900, and 0.856, respectively. These findings were further confirmed in the independent datasets and clinical samples. The selection of these specific genes was made to construct a nomogram, which demonstrated excellent diagnostic ability. Additionally, the results of the single-sample gene set enrichment analysis (ssGSEA) revealed that these genes may be involved in immune cell infiltration.
We identified four signature genes (ALAS2, HBD, EPB42, and FECH) as potential peripheral blood diagnostic candidates for AR diagnosis. Additionally, a nomogram was constructed to aid in the diagnosis of heart transplantation. This study offers valuable insights into the identification of candidate genes for heart transplantation using peripheral blood samples.
心脏移植后,心脏同种异体移植排斥反应(AR)仍然是一个严重的并发症。我们研究的主要目的是全面了解AR所涉及的基本机制,并确定可能的治疗靶点。
我们从基因表达综合数据库获取了GSE87301数据集。在GSE87301中,对有和没有心脏同种异体移植排斥反应(AR和NAR)患者的血液样本进行了比较,以检测差异表达基因(DEG)。进行富集分析以确定在AR期间显示出显著富集的途径。采用机器学习技术,包括最小绝对收缩和选择算子回归(LASSO)和随机森林(RF)算法,来识别用于诊断AR的潜在基因。使用列线图和受试者工作特征(ROC)曲线评估诊断价值。此外,分析免疫细胞浸润以探索AR中免疫细胞的任何失调。
从GSE87301数据集中共鉴定出114个DEG。这些DEG主要在与免疫系统相关的途径中富集。为了鉴定特征基因,使用了LASSO和RF算法,并鉴定出四个基因,即ALAS2、HBD、EPB42和FECH。使用受试者工作特征曲线(ROC)分析评估了这些特征基因的性能,结果显示ALAS2、HBD、EPB42和FECH的曲线下面积(AUC)值分别为0.906、0.881、0.900和0.856。这些发现在独立数据集和临床样本中得到了进一步证实。选择这些特定基因构建列线图,其显示出优异的诊断能力。此外,单样本基因集富集分析(ssGSEA)的结果表明,这些基因可能参与免疫细胞浸润。
我们鉴定出四个特征基因(ALAS2、HBD、EPB42和FECH)作为AR诊断的潜在外周血诊断候选基因。此外,构建了列线图以辅助心脏移植的诊断。本研究为利用外周血样本鉴定心脏移植候选基因提供了有价值的见解。